HealthStream (HSTM) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
10 Apr, 2026Executive summary
The 2026 Annual Meeting will be held virtually on May 28, 2026, with shareholders voting on director elections, auditor ratification, and executive compensation.
Shareholders of record as of March 30, 2026, are entitled to vote, with one vote per share.
Proxy materials are available online, and shareholders are encouraged to vote electronically to reduce environmental impact.
The Board recommends voting for all proposals, including the election of three Class II directors, ratification of Ernst & Young LLP as auditor, and approval of executive compensation.
Voting matters and shareholder proposals
Proposals include electing three Class II directors, ratifying Ernst & Young LLP as auditor, and an advisory vote on executive compensation.
No other shareholder proposals were received by the deadline; any other business will be voted at the discretion of the proxies.
Shareholders may submit proposals for the 2027 meeting by specified deadlines and procedures.
Board of directors and corporate governance
The Board consists of nine members divided into three classes, with regular skills assessments and annual evaluations.
All standing committees (Audit, Compensation, Nominating and Corporate Governance) are composed solely of independent directors.
The Lead Independent Director has significant authority, including presiding over executive sessions and acting as liaison between independent directors and management.
Board diversity includes three female members and one member of Middle Eastern ethnicity.
Directors are limited to serving on two other public company boards without approval.
Latest events from HealthStream
- Virtual annual meeting to vote on directors, auditor, and executive pay set for May 28, 2026.HSTM
Proxy filing10 Apr 2026 - Record 2025 revenue and EBITDA growth, with 2026 guidance projecting further expansion.HSTM
Q4 202513 Mar 2026 - Q2 2024 revenue up 3.4% to $71.6M, guidance reaffirmed, and SaaS platform growth continues.HSTM
Q2 20243 Feb 2026 - Record Q3 revenue, profit growth, and raised guidance highlight strong operational momentum.HSTM
Q3 202419 Jan 2026 - Strong SaaS growth, acquisitions, and platform innovation drive robust 2024 results and 2025 outlook.HSTM
Q4 202423 Dec 2025 - 2025 proxy covers director elections, auditor ratification, executive pay, and ESG priorities.HSTM
Proxy Filing1 Dec 2025 - Annual meeting to address director elections, pay, and auditor ratification.HSTM
Proxy Filing1 Dec 2025 - Record Q2 2025 revenue, profit growth, and a $25M share buyback highlight strong results.HSTM
Q2 202523 Nov 2025 - Revenue up 1%, profit down 17%; guidance trimmed, but cash flow and bookings remain strong.HSTM
Q1 202519 Nov 2025